AKT1 and Miyoshi myopathy: However, the pathway is up regulated in a significant proportion of MM patients due to the interaction of MM cells with non-malignant cells in the microenvironment, increased levels of tumor promoting cytokines and activating mutations or aberrant expression levels of other signaling pathways that feed into the PI3K/Akt pathway [20], [21], [22], [23], [24].